Report Detail
Global HGH Biosimilars Market Insights, Forecast to 2025
- RnM2676214 |
- 14 June, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of 4 hours. About 90% of the injection dose is metabolized in the liver. Only about 0.1% of the dose is excreted from the biliary tract and the kidneys.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for HGH Biosimilars in US$ by following Product Segments.: Clinical, Experiment and Others
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
The global HGH Biosimilars market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the HGH Biosimilars market based on company, product type, end user and key regions.
This report studies the global market size of HGH Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of HGH Biosimilars in these regions.
This research report categorizes the global HGH Biosimilars market by top players/brands, region, type and end user. This report also studies the global HGH Biosimilars market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market size by Product
Clinical
Experiment
Market size by End User
Treament
Prevention
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global HGH Biosimilars market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of HGH Biosimilars market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global HGH Biosimilars companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of HGH Biosimilars submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of HGH Biosimilars are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of HGH Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 HGH Biosimilars Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global HGH Biosimilars Market Size Growth Rate by Product
- 1.4.2 Clinical
- 1.4.3 Experiment
- 1.5 Market by End User
- 1.5.1 Global HGH Biosimilars Market Size Growth Rate by End User
- 1.5.2 Treament
- 1.5.3 Prevention
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global HGH Biosimilars Market Size
- 2.1.1 Global HGH Biosimilars Revenue 2014-2025
- 2.1.2 Global HGH Biosimilars Sales 2014-2025
- 2.2 HGH Biosimilars Growth Rate by Regions
- 2.2.1 Global HGH Biosimilars Sales by Regions
- 2.2.2 Global HGH Biosimilars Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 HGH Biosimilars Sales by Manufacturers
- 3.1.1 HGH Biosimilars Sales by Manufacturers
- 3.1.2 HGH Biosimilars Sales Market Share by Manufacturers
- 3.1.3 Global HGH Biosimilars Market Concentration Ratio (CR5 and HHI)
- 3.2 HGH Biosimilars Revenue by Manufacturers
- 3.2.1 HGH Biosimilars Revenue by Manufacturers (2014-2019)
- 3.2.2 HGH Biosimilars Revenue Share by Manufacturers (2014-2019)
- 3.3 HGH Biosimilars Price by Manufacturers
- 3.4 HGH Biosimilars Manufacturing Base Distribution, Product Types
- 3.4.1 HGH Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers HGH Biosimilars Product Type
- 3.4.3 Date of International Manufacturers Enter into HGH Biosimilars Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global HGH Biosimilars Sales by Product
- 4.2 Global HGH Biosimilars Revenue by Product
- 4.3 HGH Biosimilars Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global HGH Biosimilars Breakdown Data by End User
6 North America
- 6.1 North America HGH Biosimilars by Countries
- 6.1.1 North America HGH Biosimilars Sales by Countries
- 6.1.2 North America HGH Biosimilars Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America HGH Biosimilars by Product
- 6.3 North America HGH Biosimilars by End User
7 Europe
- 7.1 Europe HGH Biosimilars by Countries
- 7.1.1 Europe HGH Biosimilars Sales by Countries
- 7.1.2 Europe HGH Biosimilars Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe HGH Biosimilars by Product
- 7.3 Europe HGH Biosimilars by End User
8 Asia Pacific
- 8.1 Asia Pacific HGH Biosimilars by Countries
- 8.1.1 Asia Pacific HGH Biosimilars Sales by Countries
- 8.1.2 Asia Pacific HGH Biosimilars Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific HGH Biosimilars by Product
- 8.3 Asia Pacific HGH Biosimilars by End User
9 Central & South America
- 9.1 Central & South America HGH Biosimilars by Countries
- 9.1.1 Central & South America HGH Biosimilars Sales by Countries
- 9.1.2 Central & South America HGH Biosimilars Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America HGH Biosimilars by Product
- 9.3 Central & South America HGH Biosimilars by End User
10 Middle East and Africa
- 10.1 Middle East and Africa HGH Biosimilars by Countries
- 10.1.1 Middle East and Africa HGH Biosimilars Sales by Countries
- 10.1.2 Middle East and Africa HGH Biosimilars Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa HGH Biosimilars by Product
- 10.3 Middle East and Africa HGH Biosimilars by End User
11 Company Profiles
- 11.1 Johnson & Johnson
- 11.1.1 Johnson & Johnson Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Johnson & Johnson HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Johnson & Johnson HGH Biosimilars Products Offered
- 11.1.5 Johnson & Johnson Recent Development
- 11.2 Gilead Sciences
- 11.2.1 Gilead Sciences Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Gilead Sciences HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Gilead Sciences HGH Biosimilars Products Offered
- 11.2.5 Gilead Sciences Recent Development
- 11.3 Pacira
- 11.3.1 Pacira Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pacira HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pacira HGH Biosimilars Products Offered
- 11.3.5 Pacira Recent Development
- 11.4 Sun Pharmaceutical
- 11.4.1 Sun Pharmaceutical Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sun Pharmaceutical HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sun Pharmaceutical HGH Biosimilars Products Offered
- 11.4.5 Sun Pharmaceutical Recent Development
- 11.5 Luye Pharma
- 11.5.1 Luye Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Luye Pharma HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Luye Pharma HGH Biosimilars Products Offered
- 11.5.5 Luye Pharma Recent Development
- 11.6 Sigma-Tau Group
- 11.6.1 Sigma-Tau Group Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sigma-Tau Group HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sigma-Tau Group HGH Biosimilars Products Offered
- 11.6.5 Sigma-Tau Group Recent Development
- 11.7 Fudan-Zhangjiang
- 11.7.1 Fudan-Zhangjiang Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Fudan-Zhangjiang HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Fudan-Zhangjiang HGH Biosimilars Products Offered
- 11.7.5 Fudan-Zhangjiang Recent Development
- 11.8 Teva Pharmaceutical
- 11.8.1 Teva Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Teva Pharmaceutical HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Teva Pharmaceutical HGH Biosimilars Products Offered
- 11.8.5 Teva Pharmaceutical Recent Development
- 11.9 CSPC
- 11.9.1 CSPC Company Details
- 11.9.2 Company Business Overview
- 11.9.3 CSPC HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 CSPC HGH Biosimilars Products Offered
- 11.9.5 CSPC Recent Development
- 11.10 Novartis
- 11.10.1 Novartis Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Novartis HGH Biosimilars Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Novartis HGH Biosimilars Products Offered
- 11.10.5 Novartis Recent Development
- 11.11 Kingond Pharm
12 Future Forecast
- 12.1 HGH Biosimilars Market Forecast by Regions
- 12.1.1 Global HGH Biosimilars Sales Forecast by Regions 2019-2025
- 12.1.2 Global HGH Biosimilars Revenue Forecast by Regions 2019-2025
- 12.2 HGH Biosimilars Market Forecast by Product
- 12.2.1 Global HGH Biosimilars Sales Forecast by Product 2019-2025
- 12.2.2 Global HGH Biosimilars Revenue Forecast by Product 2019-2025
- 12.3 HGH Biosimilars Market Forecast by End User
- 12.4 North America HGH Biosimilars Forecast
- 12.5 Europe HGH Biosimilars Forecast
- 12.6 Asia Pacific HGH Biosimilars Forecast
- 12.7 Central & South America HGH Biosimilars Forecast
- 12.8 Middle East and Africa HGH Biosimilars Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 HGH Biosimilars Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on HGH Biosimilars. Industry analysis & Market Report on HGH Biosimilars is a syndicated market report, published as Global HGH Biosimilars Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of HGH Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
